This collection of novel and technology-based microbiology thesis topics is intended for MD and DNB Microbiology candidates interested in molecular diagnostics, automated identification, digital microscopy, artificial intelligence and genomic approaches to infection research. These technology-based microbiology research topics can be shaped into projects completable within one thesis period using routinely available patients, specimens and investigations, with advanced components selected only where platform access, technical supervision and funding are confirmed. A focused evaluation of an available technology can be more feasible than developing a new platform from the beginning. Each selected question should be developed into a technology-based microbiology protocol and an institution-specific technology-based microbiology synopsis.
Last reviewed and updated: September 2026 · 2026–27 admissions
Artificial Intelligence and Digital Microbiology
Diagnostic accuracy of an artificial intelligence-assisted digital Gram-stain image classifier for positive blood cultures against final culture identification in consecutive bloodstream isolates, with organism-category accuracy and reporting time assessed prospectively: a laboratory-based validation study.
Diagnostic accuracy of an artificial intelligence-assisted Gram-stain classifier for significant bacteriuria in consecutive symptomatic patients, using quantitative urine culture as reference with sensitivity and specificity assessed at forty-eight hours: a prospective validation study.
Agreement between artificial intelligence-assisted and expert interpretation of sputum Gram-stain quality in consecutive lower respiratory specimens, using final culture suitability as reference with concordance assessed before culture reporting: a diagnostic validation study.
Diagnostic performance of a deep-learning image classifier for automated acid-fast bacillus detection in archived Ziehl-Neelsen-stained sputum smears, using expert microscopy as reference with sensitivity and slide-reading time assessed retrospectively.
Diagnostic performance of an artificial intelligence-assisted fluorescent smear reader for pulmonary tuberculosis in consecutively archived sputum slides, using expert microscopy and molecular tuberculosis testing as comparators with agreement assessed after digital analysis.
Agreement between smartphone-assisted digital microscopy and conventional light microscopy for malaria parasite detection in febrile patients, using expert peripheral-smear interpretation as reference with species concordance assessed on the same slides.
Diagnostic accuracy of an artificial intelligence-assisted malaria parasite image classifier in archived peripheral blood smears, using expert microscopy as reference with species identification and parasitemia-category agreement assessed after digital analysis.
Diagnostic accuracy of computer-assisted fungal-element recognition in digital potassium hydroxide mount images from patients with suspected dermatophytosis, using fungal culture as reference with sensitivity and specificity assessed at final culture reporting.
Agreement between automated digital colony counting and manual colony counting in consecutive quantitative urine cultures, using manual calibrated counting as reference with colony-count agreement and technician time assessed after overnight incubation.
Diagnostic performance of artificial intelligence-assisted colony image analysis for differentiating common urinary pathogens on chromogenic agar, using conventional biochemical or automated identification as reference with species accuracy assessed after overnight incubation.
Diagnostic performance of a machine-learning model using routine blood culture time-to-positivity, Gram-stain morphology, and patient variables for predicting Gram-negative bacteraemia, using final culture identification as reference with discrimination assessed at culture positivity.
Validation of a machine-learning model for predicting carbapenem resistance among Klebsiella pneumoniae bloodstream isolates using routine demographic, specimen, and preliminary laboratory variables, with final susceptibility testing as reference and prediction assessed before susceptibility reporting.
Validation of a machine-learning model for predicting multidrug-resistant urinary tract infection from routine clinical and laboratory variables in adult inpatients, using final urine culture susceptibility as reference with discrimination assessed at initial culture positivity.
Development and internal validation of an explainable machine-learning model for predicting blood culture contamination from bottle positivity pattern, time to positivity, organism identity, and clinical variables, with adjudicated contamination status assessed during admission.
Development and temporal validation of a machine-learning model for predicting blood culture positivity among adults evaluated for sepsis, using routine haematological and inflammatory parameters with final culture result assessed during the index episode.
Diagnostic accuracy of artificial intelligence-assisted interpretation of inhibition-zone images for disc diffusion susceptibility testing in Enterobacterales, using expert manual measurement as reference with categorical agreement assessed after overnight incubation.
Agreement between smartphone-based automated inhibition-zone measurement and manual ruler measurement in Escherichia coli and Klebsiella pneumoniae isolates, using current Clinical and Laboratory Standards Institute breakpoints with categorical agreement assessed prospectively.
Validation of machine-learning prediction of antimicrobial resistance from matrix-assisted laser desorption ionization time-of-flight mass spectrometry spectra of Escherichia coli where routinely available, using standard susceptibility testing as reference after isolate characterization.
Validation of machine-learning prediction of methicillin resistance from matrix-assisted laser desorption ionization time-of-flight mass spectrometry spectra of Staphylococcus aureus where routinely available, using cefoxitin susceptibility as reference after isolate characterization.
Comparative evaluation of artificial intelligence-assisted versus conventional manual review of routine microbiology laboratory images and results, using expert verification as reference with diagnostic discrepancies and technologist review time assessed over six months.
Rapid Molecular and Point-of-Care Diagnostics
Diagnostic accuracy of loop-mediated isothermal amplification for Mycobacterium tuberculosis complex in residual sputum specimens from adults with suspected pulmonary tuberculosis, using cartridge-based nucleic acid amplification testing and culture as references at final diagnosis.
Diagnostic accuracy of loop-mediated isothermal amplification for Mycobacterium tuberculosis complex in residual extrapulmonary specimens, using mycobacterial culture or established molecular testing as reference with specimen-specific sensitivity assessed at final diagnosis.
Comparative diagnostic performance of loop-mediated isothermal amplification and conventional polymerase chain reaction for detecting selected carbapenemase genes in stored Enterobacterales isolates, with gene-detection agreement and turnaround time assessed after testing.
Diagnostic accuracy of recombinase polymerase amplification for selected bacterial resistance determinants in stored carbapenem-resistant Enterobacterales, using conventional polymerase chain reaction as reference with sensitivity and time-to-result assessed after isolate characterization.
Diagnostic accuracy of digital polymerase chain reaction for low-level hepatitis B virus deoxyribonucleic acid detection in archived clinically tested serum specimens, using routinely performed real-time molecular testing as comparator with quantitative agreement assessed after analysis.
Agreement between digital polymerase chain reaction and real-time polymerase chain reaction for cytomegalovirus quantification in archived positive plasma specimens from immunocompromised patients, with quantitative concordance assessed after paired testing.
Diagnostic accuracy of clustered regularly interspaced short palindromic repeats-associated nucleic acid detection for dengue virus in archived acute-phase serum specimens, using validated real-time molecular testing as reference with sensitivity assessed by illness day.
Diagnostic accuracy of clustered regularly interspaced short palindromic repeats-associated detection for severe acute respiratory syndrome coronavirus 2 in residual respiratory specimens, using real-time reverse transcription polymerase chain reaction as reference with turnaround time assessed same day.
Diagnostic accuracy of clustered regularly interspaced short palindromic repeats-associated detection for Mycobacterium tuberculosis complex in residual sputum specimens, using cartridge-based nucleic acid amplification testing as reference with sensitivity and time-to-result assessed prospectively.
Diagnostic accuracy of a lateral-flow nucleic acid detection assay following isothermal amplification for scrub typhus in residual blood specimens, using validated molecular testing or immunoglobulin M enzyme linked immunosorbent assay as reference during acute illness.
Comparative diagnostic performance of rapid microfluidic molecular testing and conventional culture for common bloodstream pathogens from positive blood culture bottles, with species concordance and time to actionable identification assessed prospectively.
Diagnostic yield of a multiplex molecular respiratory panel in hospitalised patients with severe acute respiratory illness, using conventional targeted virological testing as comparator with additional pathogen detections assessed during the same admission.
Diagnostic yield of a multiplex molecular meningitis panel in residual cerebrospinal fluid from patients with suspected central nervous system infection, using microscopy, culture, and routine molecular tests as comparators during admission.
Diagnostic performance of a syndromic gastrointestinal molecular panel in residual stool specimens from hospitalised patients with acute diarrhoea, using conventional bacterial, viral, and parasitic testing as comparator with incremental yield assessed after testing.
Diagnostic accuracy of a rapid molecular assay for methicillin resistance directly from positive blood culture bottles containing Gram-positive cocci, using final Staphylococcus aureus identification and cefoxitin susceptibility as reference within twenty-four hours.
Diagnostic accuracy of rapid molecular detection of common carbapenemase genes directly from carbapenem-resistant Enterobacterales isolates, using phenotypic carbapenemase testing as comparator with genotype-phenotype agreement assessed after isolate characterization.
Comparative evaluation of direct-from-specimen molecular detection and conventional culture for Neisseria gonorrhoeae and Chlamydia trachomatis in routinely collected genital specimens, with diagnostic yield and turnaround time assessed during the same episode.
Diagnostic accuracy of a rapid molecular assay for influenza virus and respiratory syncytial virus in residual respiratory specimens, using laboratory real-time molecular testing as reference with sensitivity assessed during acute illness.
Diagnostic accuracy of point-of-care molecular testing for hepatitis C virus in antibody-reactive patients where routinely available, using central-laboratory molecular testing as reference with concordance and time-to-confirmation assessed during the same visit.
Comparative clinical-laboratory utility of rapid molecular and conventional microbiological testing in culture-negative suspected infection, using final clinical diagnosis as reference with diagnostic yield and time to actionable result assessed during admission.
Genomics, Metagenomics and Nanopore Sequencing
Agreement between nanopore sequencing and conventional identification for bacterial species recovered from positive blood culture bottles where sequencing is available, with species concordance and time to identification assessed prospectively.
Diagnostic performance of nanopore sequencing for antimicrobial resistance determinant detection in carbapenem-resistant Klebsiella pneumoniae isolates, using phenotypic susceptibility and targeted polymerase chain reaction as references after isolate characterization.
Genotype-phenotype concordance of antimicrobial resistance predicted by nanopore sequencing among stored Escherichia coli urinary isolates, using routine susceptibility testing as reference with categorical agreement assessed after sequencing.
Comparative evaluation of nanopore sequencing and conventional molecular testing for carbapenemase genes in stored carbapenem-resistant Enterobacterales, with gene-detection agreement and turnaround time assessed after isolate characterization.
Diagnostic yield of nanopore metagenomic sequencing from residual positive blood culture material, using conventional culture identification as reference with species detection and resistance-gene recovery assessed after sequencing.
Diagnostic yield of metagenomic sequencing in archived culture-negative cerebrospinal fluid from patients with clinically suspected central nervous system infection, using final clinical diagnosis as comparator with additional pathogen detection assessed retrospectively.
Diagnostic yield of metagenomic sequencing in residual lower respiratory specimens from immunocompromised patients with unresolved pneumonia, using routine microbiology as comparator with additional pathogen detections assessed during the diagnostic episode.
Comparative diagnostic yield of targeted sequencing and conventional culture for bacterial pathogens in residual sterile body fluid specimens, using composite microbiological diagnosis as reference with concordance assessed at final reporting.
Genomic characterization of resistance and virulence determinants in stored carbapenem-resistant Klebsiella pneumoniae bloodstream isolates, using whole-genome sequencing and phenotypic susceptibility with genotype-phenotype concordance assessed retrospectively.
Whole-genome sequencing-based comparison of stored methicillin-resistant Staphylococcus aureus isolates from bloodstream and wound infections, using routine phenotypic profiles as comparator with resistance and virulence determinants assessed after sequencing.
Whole-genome sequencing-based characterization of vancomycin-resistant Enterococcus faecium isolates from high-risk wards, using routine susceptibility and ward-time data with resistance determinants and relatedness assessed retrospectively.
Whole-genome sequencing-based assessment of suspected transmission among carbapenem-resistant Acinetobacter baumannii isolates from intensive care patients, using routine epidemiological linkage as comparator with genomic relatedness assessed after sequencing.
Comparative evaluation of genomic and phenotypic antimicrobial resistance prediction among stored Pseudomonas aeruginosa isolates, using whole-genome sequencing and routine susceptibility testing with categorical concordance assessed retrospectively.
Plasmid and resistance-gene characterization of carbapenem-resistant Klebsiella pneumoniae using long-read sequencing where available, with phenotypic susceptibility as comparator and resistance architecture assessed after isolate sequencing.
Comparative evaluation of long-read and short-read sequencing for resistance-gene and plasmid detection in selected multidrug-resistant Enterobacterales, using assembled genomic results with concordance assessed after sequencing.
Metagenomic characterization of antimicrobial resistance genes in archived stool specimens from patients colonized with carbapenem-resistant Enterobacterales, using culture-based screening as comparator with resistome profiles assessed after sequencing.
Comparative resistome analysis of residual stool specimens from intensive care and general-ward patients where sequencing is available, using culture-detected multidrug-resistant organism carriage as comparator with resistance-gene burden assessed cross-sectionally.
Metagenomic comparison of bacterial communities in residual stool specimens from patients with and without antibiotic-associated diarrhoea, using routine microbiology as comparator with microbial diversity and pathogen signals assessed after sequencing.
Metagenomic characterization of respiratory microbial communities in residual endotracheal aspirates from ventilated patients with and without ventilator-associated pneumonia, using conventional cultures as comparator with community profiles assessed at diagnosis.
Retrospective genomic surveillance of stored multidrug-resistant Gram-negative isolates from a teaching hospital using available sequencing data, with routine antibiograms and ward distribution as comparators and transmission clusters assessed over two years.
Advanced Antimicrobial Resistance and Rapid Susceptibility Testing
Agreement between rapid direct disc diffusion from positive blood culture bottles and standard colony-based susceptibility testing for Enterobacterales, using current Clinical and Laboratory Standards Institute breakpoints with categorical agreement assessed within twenty-four hours.
Agreement between rapid direct disc diffusion and conventional susceptibility testing for Staphylococcus aureus from positive blood culture bottles, with categorical concordance and reduction in reporting time assessed prospectively.
Diagnostic performance of microfluidic rapid phenotypic susceptibility testing for Escherichia coli urinary isolates where available, using broth microdilution as reference with categorical agreement and time-to-result assessed same day.
Diagnostic performance of microfluidic rapid phenotypic susceptibility testing for Klebsiella pneumoniae bloodstream isolates where available, using broth microdilution as reference with essential agreement and reporting time assessed prospectively.
Agreement between automated single-cell growth analysis and standard broth microdilution for antimicrobial susceptibility of Enterobacterales where available, with categorical agreement assessed within the same working day.
Comparative evaluation of rapid colorimetric susceptibility testing and standard broth microdilution for carbapenem-resistant Enterobacterales, with categorical agreement and time-to-result assessed after isolate characterization.
Diagnostic accuracy of a rapid resazurin-based microtitre susceptibility method for selected antibiotics against broth microdilution among multidrug-resistant Gram-negative isolates, with categorical agreement assessed within eight hours.
Diagnostic accuracy of a rapid metabolic susceptibility assay for urinary Escherichia coli against routine disc diffusion, with categorical agreement and time to susceptibility result assessed on the day of culture positivity.
Agreement between automated digital inhibition-zone measurement and manual disc diffusion interpretation among Enterobacterales, using current Clinical and Laboratory Standards Institute breakpoints with error rates assessed after overnight incubation.
Validation of smartphone-based automated susceptibility plate interpretation among Escherichia coli and Klebsiella pneumoniae isolates, using expert manual readings as reference with categorical agreement assessed prospectively.
Diagnostic accuracy of matrix-assisted laser desorption ionization time-of-flight mass spectrometry-based hydrolysis testing for carbapenemase activity where available, using molecular carbapenemase detection as reference with sensitivity assessed after isolate characterization.
Diagnostic performance of a rapid lateral-flow immunoassay for common carbapenemase proteins in carbapenem-resistant Enterobacterales, using molecular gene detection as reference with sensitivity and turnaround time assessed after isolate testing.
Agreement between rapid lateral-flow detection of carbapenemase proteins and modified carbapenem inactivation testing among carbapenem-resistant Klebsiella pneumoniae, with discordant isolates resolved molecularly after characterization.
Diagnostic accuracy of an immunochromatographic assay for altered penicillin-binding protein detection in Staphylococcus aureus, using cefoxitin susceptibility and molecular resistance detection as references with concordance assessed same day.
Association of heteroresistance detected by population-based susceptibility testing with treatment outcome among carbapenem-resistant Gram-negative bloodstream isolates, using standard susceptibility categories as comparator and clinical outcome assessed at discharge.
Frequency and reproducibility of heteroresistant subpopulations among carbapenem-resistant Klebsiella pneumoniae using gradient or population-analysis methods, with standard broth microdilution as comparator and repeat testing completed within one week.
Genotypic-phenotypic concordance of colistin resistance among clinically indicated multidrug-resistant Gram-negative isolates, using broth microdilution and routinely available resistance-gene detection with agreement assessed after isolate characterization.
Association of biofilm biomass with rapid phenotypic susceptibility patterns among Pseudomonas aeruginosa isolates from device-associated infections, using microtitre plate biofilm assay and standard susceptibility testing assessed after isolate characterization.
Validation of a machine-learning model combining species identification, routine susceptibility results, and hospital location to predict carbapenemase production among Enterobacterales, using phenotypic or molecular confirmation as reference at final reporting.
Comparative evaluation of routine, rapid phenotypic, and molecular resistance testing for carbapenem-resistant Enterobacterales, with reference characterization used to assess diagnostic agreement and time to actionable resistance information prospectively.
Laboratory Automation, Digital Epidemiology and Smart Surveillance
Comparative evaluation of automated digital plate imaging and manual culture reading for consecutive urine specimens, using expert verified culture as reference with detection agreement and technologist reading time assessed after overnight incubation.
Diagnostic performance of automated digital culture-plate analysis for negative urine culture screening, using final manual culture interpretation as reference with negative predictive value and reporting-time reduction assessed prospectively.
Comparative evaluation of automated digital colony recognition and conventional manual reading of chromogenic urine cultures, using final organism identification as reference with species-level agreement assessed after overnight incubation.
Agreement between automated blood culture analytics incorporating time-to-positivity patterns and conventional clinical adjudication for distinguishing contaminants from true bacteraemia, with classification accuracy assessed during the index admission.
Validation of an electronic laboratory alert system for early recognition of carbapenem-resistant Enterobacterales clusters, using infection-control surveillance review as reference with alert sensitivity and time-to-cluster detection assessed prospectively.
Validation of an automated laboratory-information-system alert for possible hospital transmission of Acinetobacter baumannii based on ward, time, and antibiogram similarity, using infection-control investigation as reference over twelve months.
Comparative detection of healthcare-associated infection clusters by automated temporal-spatial analytics and conventional manual surveillance, using infection-control adjudication as reference with cluster-detection time assessed over twelve months.
Development and validation of a digital dashboard for real-time intensive care unit antibiogram surveillance, using routinely verified susceptibility data with agreement to conventional annual antibiograms assessed after twelve months.
Comparison of continuously updated electronic antibiograms with conventional annual antibiograms for empirical coverage prediction in bloodstream infection, using final susceptibility results from the subsequent six months as reference.
Validation of a computerized decision-support model for empirical antibiotic selection in adult bloodstream infection, using local microbiology data and final susceptibility as reference with predicted coverage assessed at culture reporting.
Development and temporal validation of an electronic risk model for carbapenem-resistant Gram-negative infection among intensive care patients, using routine admission and microbiology data with culture-confirmed resistance assessed during hospitalisation.
Development and validation of an automated rule-based system for recognizing unusual antimicrobial susceptibility patterns requiring confirmatory testing, using expert microbiologist review as reference with alert accuracy assessed before report release.
Audit of automated interpretive comments generated from antimicrobial susceptibility results, using microbiologist-approved comments as reference with appropriateness and potential reporting-time reduction assessed over six months.
Comparative evaluation of automated and manual cumulative antibiogram generation from laboratory information systems, using verified first-isolate rules with agreement in susceptibility proportions assessed for one annual dataset.
Validation of digital barcode-based specimen tracking for blood cultures, using conventional accession records as comparator with specimen identification errors and transport-to-incubation time assessed over three months.
Before-and-after evaluation of electronic specimen-rejection alerts in a microbiology laboratory, using predefined rejection criteria with inappropriate specimen processing and recollection delays assessed during equal three-month periods.
Validation of automated turnaround-time monitoring for blood culture, urine culture, and molecular tuberculosis testing, using manual quality records as comparator with delay detection and reporting accuracy assessed over six months.
Development and validation of an electronic prediction model for blood culture contamination using collection site, bottle pattern, time to positivity, and organism identity, with clinical adjudication as reference during the same admission.
Comparative evaluation of digital environmental surveillance mapping and conventional tabular surveillance for multidrug-resistant organism recovery from intensive care surfaces, using culture-confirmed contamination with cluster recognition assessed over six months.
Validation of an integrated smart microbiology surveillance dashboard combining antimicrobial resistance, bloodstream infection, device-associated infection, and environmental culture data, using conventional infection-control reports as comparator with concordance and alert timeliness assessed over twelve months.
Not the microbiology subspeciality you need? Novel and technology-based microbiology is one section of our full microbiology collection — the hub page lists every subspeciality, each with its own free topic list. Updated September 2026.
📌 Updated for 2026–2027 MD and DNB Novel and Technology-Based Microbiology admissions
The accompanying methodological guidance has been reviewed for independent evaluation, appropriate reference methods, contamination controls and realistic laboratory costs.
Choose technologies already accessible locally or through a confirmed collaboration: molecular assays, automated identification, MALDI-TOF, digital microscopy or sequencing each require different equipment, consumables and expertise.
Developing a new AI model, purchasing a sequencer or running metagenomics is not required for every project; evaluating an existing method against a justified comparator can answer a useful research question.
Publication potential rests on reproducible performance in a defined setting, credible handling of errors and evidence of practical usefulness, rather than novelty claims based only on the platform name.
Generate a protocol from any topic above
Select Generate Protocol → beside any title in the list above and receive a submission-ready document built around that topic, containing all eighteen components:
Introduction / Synopsis
Research Question
Aim of the Study
Primary Objective
Secondary Objectives
Materials and Methods
Inclusion Criteria
Exclusion Criteria
Sample Size Calculation
Methodology
Statistical Analysis
Ethical Considerations
Review of Literature
References
Gantt Chart / Study Timeline
Patient Information Sheet
Consent Form
Data Collection Form
Already have your thesis title?
Generate the full novel and technology-based microbiology protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.
Alongside novel and technology-based microbiology protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.
Novel and technology-based microbiology research outside India
The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the novel and technology-based microbiology research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.
Board and residency programmes — country by country
Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the novel and technology-based microbiology research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.
United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare a novel and technology-based microbiology research protocol for their programme and submit it for institutional review board approval before any data are collected.
Qatar — DHP (formerly QCHP) and Hamad Medical Corporation. A novel and technology-based microbiology IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.
Bahrain — NHRA. Trainees turning novel and technology-based microbiology research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.
Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the novel and technology-based microbiology research proposal is the document assessed at the start of it.
Kuwait — KIMS. A novel and technology-based microbiology study protocol goes to the institutional committee for approval before the project begins.
Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the novel and technology-based microbiology proposal follows the same structure throughout.
Postgraduate degrees — Malaysia, the Gulf and beyond
Malaysia — MMed, the National Medical Research Register and MREC. A novel and technology-based microbiology dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.
PhD and Master's candidates elsewhere. University programmes generally require a full novel and technology-based microbiology research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.
PhD and MMed proposals are written individually by a medical doctor and revised until the supervisor accepts them. They are not produced by the automated protocol generator.
🔥 Trending research areas in Novel and Technology-Based Microbiology for 2026–27
AI-assisted microscopy and identification: evaluating performance on independently labelled local specimens, including poor-quality images and uncommon classes, rather than reporting accuracy only on selected examples.
Rapid molecular and isothermal assays: assessing detection limits, inhibition, cross-reactivity and workflow time to determine whether faster amplification produces a dependable report.
Targeted sequencing and metagenomic detection: examining additional diagnostic yield while separating clinically plausible findings from background contamination and incidental detections.
Genomic prediction of antimicrobial resistance: comparing defined prediction pipelines with phenotypic susceptibility results and investigating discordance without assuming that a detected gene always determines the phenotype.
Protocol and synopsis guidance
What a Novel and Technology-Based Microbiology protocol must contain
Specify the intended use and development stage. State whether the project evaluates analytical performance, clinical diagnostic performance, workflow impact or model development. Define the target organism or condition, specimen type, intended users, primary endpoint and reference method. A detection limit measured in spiked material does not establish sensitivity in consecutive patient specimens.
Lock the evaluated method. Record instrument, assay, software, model and database versions, preprocessing steps, decision thresholds and failed-run rules. For a hosted AI model, retain the accessible version identifier, prompts, settings, evaluation dates and returned outputs. Document changes during the study rather than pooling different versions without explanation.
Protect independence. Assign all related images, aliquots and repeated samples from a patient or isolate to the same development or evaluation partition. Fit preprocessing and choose thresholds within development data. Keep the final test set untouched until the method is fixed. Record the source and blinding of reference labels; a reference diagnosis influenced by the evaluated test can inflate apparent accuracy.
Control the complete workflow. Molecular and sequencing studies need appropriate extraction, negative and positive controls, inhibition assessment and predefined contamination handling. Record invalid runs, repeats, reagent lots, reportability, operator time and cost per reportable result. Distinguish instrument run time from specimen-to-report time and from any subsequent clinical action.
Novel and Technology-Based Microbiology synopsis versus Novel and Technology-Based Microbiology protocol
The synopsis presents the proposed question, rationale, design, sample-size basis and essential methods for institutional review. The protocol describes how the evaluation will actually be performed, although institutional terminology can overlap.
In technology studies, the synopsis should already identify the platform, its development stage, the comparator and the independent evaluation population. The full protocol adds version control, data partitioning, specimen processing, failed-test handling, threshold selection and access to technical support. Keep analytical validation, clinical validation and implementation outcomes distinct in both documents; successful laboratory detection alone does not demonstrate improved patient outcomes.
Sample size and statistical analysis
Count independent biological units. Hundreds of image patches from a few slides do not represent hundreds of patients. Base sample-size planning on the primary endpoint and independent patient, specimen or isolate count, with clustering addressed where necessary. For diagnostic evaluation, plan sufficient reference-positive and reference-negative units for the intended precision and allow for invalid tests.
Match statistics to the claim. Report sensitivity, specificity and confidence intervals against a justified reference, or agreement when neither method establishes the true state. Include class-specific results for multiclass identification and avoid relying only on overall accuracy in imbalanced datasets. For probabilistic prediction, assess calibration as well as discrimination; a high area under the curve does not show that predicted risks are accurate.
Separate development from evaluation. Use resampling appropriate to the available data for development, with all tuning confined to the training process. A held-out sample from the same source provides internal evaluation, not evidence of transportability to another laboratory. Report the limits of any temporal or external evaluation. The TRIPOD+AI reporting guidance is relevant to prediction-model studies; it is a reporting framework, not a substitute for adequate design.
1. How do I choose a feasible novel or technology-based microbiology thesis topic?
For 2026–2027 admissions, select a focused question around a platform that is already accessible. Confirm patient or isolate numbers, reference testing, consumables, technical supervision and data access before committing. A local evaluation of an established technology may be feasible within an MD or DNB thesis even when developing a new assay or model is not.
2. Which study designs suit technology-based microbiology research?
Options include analytical assay evaluations, paired diagnostic-method comparisons, diagnostic-accuracy studies, prospective workflow studies and prediction-model development or evaluation. Choose the design according to the primary claim. Studies using spiked samples or selected archived positives should state those limitations and should not be presented as evaluations of routine clinical performance.
3. What should I agree with my guide before finalising the title?
Agree on intended use, platform and version, development stage, primary endpoint, independent sampling unit, reference standard and budget. Confirm permissions for images, sequences or clinical records, technical support and any collaborating laboratory. Establish whether enough independent data exist for development and evaluation, and avoid promising clinical benefit if the study measures only laboratory performance.
4. Can I undertake a technology-based thesis without an expensive platform in my department?
Yes, if the proposed question can use existing digital images, routine laboratory data or a formally agreed external testing service. Confirm the external laboratory's costs, turnaround time, specimen-transfer arrangements, quality controls and access to the results needed for analysis. Public datasets may support a methods study, but check their provenance, licence, duplicate samples and suitability for the intended population. Do not assume that results obtained elsewhere establish local clinical performance.
5. How does a technology-based microbiology synopsis differ from a protocol?
The synopsis usually supports institutional submission and registration, while the protocol supplies the detailed conduct plan. Both should identify the evaluated technology, comparator, primary outcome and independent evaluation sample. The protocol additionally documents software and assay versions, preprocessing, threshold selection, controls, failures, repeat testing and the analysis of discordant results.
6. What ethical safeguards are needed for technology-based microbiology research?
Obtain ethics review and applicable consent or an approved waiver for retrospective records and residual samples. For children, include guardian permission and age-appropriate assent from about seven years, as applicable. A residual-sample design should specify no extra radiation, contrast or research-only venepuncture and 0 mL additional research blood; any extra collection needs an approved numerical volume and frequency limit. Obtain separate consent for identifiable photographs or video.
Remove identifiers from images and metadata, restrict access and obtain approval for external data processing; sequencing may also capture human genetic information. Route unexpected clinically significant detections through the consultant microbiologist and treating clinician, with infection-control involvement where appropriate. Define clinical confirmation before acting on research outputs.
7. Why can an AI microbiology model show excellent accuracy but fail on new patients?
Related images or specimens may appear in both training and test data, allowing the model to recognise patient, slide or batch features instead of the intended biological signal. Split data at the patient or independent-isolate level before augmentation, keep related samples together and perform feature selection and threshold tuning only within development data. An untouched evaluation set should reflect the intended clinical population. Changes in equipment, staining, prevalence or reference labels can still reduce performance at another centre.
8. Can these topics support a PhD proposal or a Gulf board research project?
Yes, with adaptation. A PhD proposal needs a substantive original contribution beyond the usual MD synopsis. For SCFHS and Saudi Board programmes, the Arab Board of Health Specializations, and DHP-, DHA-, DOH- or MOHAP-linked training programmes, confirm the applicable curriculum, supervision and local ethics requirements. Where a board research project is mandatory, align its scope and assessment milestones with that programme. Do not assume a uniform research requirement across these bodies and linked programmes.
9. When should I register a novel or technology-based microbiology thesis topic?
Follow the university or training board deadline after guide agreement and a feasibility review. Resolve platform access, collaboration, technical support and the analysis plan before registration. Obtain the required approvals before research use of identifiable data, recruitment or specimen testing, and allow time for pilot optimisation, failed runs, independent evaluation and dissertation submission.
Found a topic that fits your department?
Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.
